| Product Code: ETC7655167 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Lung Transplant Therapeutics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Lung Transplant Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Lung Transplant Therapeutics Market - Industry Life Cycle |
3.4 Israel Lung Transplant Therapeutics Market - Porter's Five Forces |
3.5 Israel Lung Transplant Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Lung Transplant Therapeutics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Israel Lung Transplant Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Israel Lung Transplant Therapeutics Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.9 Israel Lung Transplant Therapeutics Market Revenues & Volume Share, By Patient Demographics, 2021 & 2031F |
4 Israel Lung Transplant Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in Israel |
4.2.2 Technological advancements in lung transplant procedures |
4.2.3 Growing awareness about the importance of lung transplants in improving quality of life |
4.3 Market Restraints |
4.3.1 Limited availability of donor lungs for transplant |
4.3.2 High costs associated with lung transplant procedures |
4.3.3 Stringent regulatory requirements for approval of lung transplant therapeutics |
5 Israel Lung Transplant Therapeutics Market Trends |
6 Israel Lung Transplant Therapeutics Market, By Types |
6.1 Israel Lung Transplant Therapeutics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Immunosuppressant Drugs, 2021- 2031F |
6.1.4 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Organ Preservation Products, 2021- 2031F |
6.1.5 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Tissue Products, 2021- 2031F |
6.2 Israel Lung Transplant Therapeutics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Chronic Obstructive Pulmonary Diseases (COPD), 2021- 2031F |
6.2.3 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Pulmonary Fibrosis, 2021- 2031F |
6.2.4 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Septic Lung Disease, 2021- 2031F |
6.2.5 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Pulmonary Hypertension, 2021- 2031F |
6.2.6 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.7 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Interstitial Pulmonary Fibrosis, 2021- 2031F |
6.2.8 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.2.9 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.3 Israel Lung Transplant Therapeutics Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Cadaveric Lung Transplantation, 2021- 2031F |
6.3.3 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Living Lung Transplantation, 2021- 2031F |
6.4 Israel Lung Transplant Therapeutics Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Single-Lung Transplantation, 2021- 2031F |
6.4.3 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Bilateral-Lung Transplantation, 2021- 2031F |
6.4.4 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Heart-Lung Transplantation, 2021- 2031F |
6.4.5 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Double Lung Transplantation, 2021- 2031F |
6.5 Israel Lung Transplant Therapeutics Market, By Patient Demographics |
6.5.1 Overview and Analysis |
6.5.2 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5.3 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Adult, 2021- 2031F |
6.5.4 Israel Lung Transplant Therapeutics Market Revenues & Volume, By Paediatric, 2021- 2031F |
7 Israel Lung Transplant Therapeutics Market Import-Export Trade Statistics |
7.1 Israel Lung Transplant Therapeutics Market Export to Major Countries |
7.2 Israel Lung Transplant Therapeutics Market Imports from Major Countries |
8 Israel Lung Transplant Therapeutics Market Key Performance Indicators |
8.1 Average waiting time for lung transplant surgery |
8.2 Success rate of lung transplant procedures in Israel |
8.3 Number of research and development initiatives focused on improving lung transplant outcomes |
9 Israel Lung Transplant Therapeutics Market - Opportunity Assessment |
9.1 Israel Lung Transplant Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Lung Transplant Therapeutics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Israel Lung Transplant Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Israel Lung Transplant Therapeutics Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.5 Israel Lung Transplant Therapeutics Market Opportunity Assessment, By Patient Demographics, 2021 & 2031F |
10 Israel Lung Transplant Therapeutics Market - Competitive Landscape |
10.1 Israel Lung Transplant Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Israel Lung Transplant Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here